TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.

To better understand the roles of TGF-beta in bone metabolism, we investigated osteoclast survival in response TGF-beta and found that TGF-beta inhibited apoptosis. We examined the receptors involved in promotion of osteoclast survival and found that the canonical TGF-beta receptor complex is involv...

Full description

Bibliographic Details
Main Authors: Gingery, A, Bradley, E, Pederson, L, Ruan, M, Horwood, N, Oursler, M
Format: Journal article
Language:English
Published: 2008
_version_ 1797081395454017536
author Gingery, A
Bradley, E
Pederson, L
Ruan, M
Horwood, N
Oursler, M
author_facet Gingery, A
Bradley, E
Pederson, L
Ruan, M
Horwood, N
Oursler, M
author_sort Gingery, A
collection OXFORD
description To better understand the roles of TGF-beta in bone metabolism, we investigated osteoclast survival in response TGF-beta and found that TGF-beta inhibited apoptosis. We examined the receptors involved in promotion of osteoclast survival and found that the canonical TGF-beta receptor complex is involved in the survival response. The upstream MEK kinase TAK1 was rapidly activated following TGF-beta treatment. Since osteoclast survival involves MEK, AKT, and NFkappaB activation, we examined TGF-beta effects on activation of these pathways and observed rapid phosphorylation of MEK, AKT, IKK, IkappaB, and NFkappaB. The timing of activation coincided with SMAD activation and dominant negative SMAD expression did not inhibit NFkappaB activation, indicating that kinase pathway activation is independent of SMAD signaling. Inhibition of TAK1, MEK, AKT, NIK, IKK, or NFkappaB repressed TGF-beta-mediated osteoclast survival. Adenoviral-mediated TAK1 or MEK inhibition eliminated TGF-beta-mediated kinase pathway activation and constitutively active AKT expression overcame apoptosis induction following MEK inhibition. TAK1/MEK activation induces pro-survival BclX(L) expression and TAK1/MEK and SMAD pathway activation induces pro-survival Mcl-1 expression. These data show that TGF-beta-induced NFkappaB activation is through TAK1/MEK-mediated AKT activation, which is essential for TGF-beta to support of osteoclast survival.
first_indexed 2024-03-07T01:13:53Z
format Journal article
id oxford-uuid:8df9bce7-88aa-481b-8957-4f6a7a6bb040
institution University of Oxford
language English
last_indexed 2024-03-07T01:13:53Z
publishDate 2008
record_format dspace
spelling oxford-uuid:8df9bce7-88aa-481b-8957-4f6a7a6bb0402022-03-26T22:54:38ZTGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8df9bce7-88aa-481b-8957-4f6a7a6bb040EnglishSymplectic Elements at Oxford2008Gingery, ABradley, EPederson, LRuan, MHorwood, NOursler, MTo better understand the roles of TGF-beta in bone metabolism, we investigated osteoclast survival in response TGF-beta and found that TGF-beta inhibited apoptosis. We examined the receptors involved in promotion of osteoclast survival and found that the canonical TGF-beta receptor complex is involved in the survival response. The upstream MEK kinase TAK1 was rapidly activated following TGF-beta treatment. Since osteoclast survival involves MEK, AKT, and NFkappaB activation, we examined TGF-beta effects on activation of these pathways and observed rapid phosphorylation of MEK, AKT, IKK, IkappaB, and NFkappaB. The timing of activation coincided with SMAD activation and dominant negative SMAD expression did not inhibit NFkappaB activation, indicating that kinase pathway activation is independent of SMAD signaling. Inhibition of TAK1, MEK, AKT, NIK, IKK, or NFkappaB repressed TGF-beta-mediated osteoclast survival. Adenoviral-mediated TAK1 or MEK inhibition eliminated TGF-beta-mediated kinase pathway activation and constitutively active AKT expression overcame apoptosis induction following MEK inhibition. TAK1/MEK activation induces pro-survival BclX(L) expression and TAK1/MEK and SMAD pathway activation induces pro-survival Mcl-1 expression. These data show that TGF-beta-induced NFkappaB activation is through TAK1/MEK-mediated AKT activation, which is essential for TGF-beta to support of osteoclast survival.
spellingShingle Gingery, A
Bradley, E
Pederson, L
Ruan, M
Horwood, N
Oursler, M
TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.
title TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.
title_full TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.
title_fullStr TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.
title_full_unstemmed TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.
title_short TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.
title_sort tgf beta coordinately activates tak1 mek akt nfkb and smad pathways to promote osteoclast survival
work_keys_str_mv AT gingerya tgfbetacoordinatelyactivatestak1mekaktnfkbandsmadpathwaystopromoteosteoclastsurvival
AT bradleye tgfbetacoordinatelyactivatestak1mekaktnfkbandsmadpathwaystopromoteosteoclastsurvival
AT pedersonl tgfbetacoordinatelyactivatestak1mekaktnfkbandsmadpathwaystopromoteosteoclastsurvival
AT ruanm tgfbetacoordinatelyactivatestak1mekaktnfkbandsmadpathwaystopromoteosteoclastsurvival
AT horwoodn tgfbetacoordinatelyactivatestak1mekaktnfkbandsmadpathwaystopromoteosteoclastsurvival
AT ourslerm tgfbetacoordinatelyactivatestak1mekaktnfkbandsmadpathwaystopromoteosteoclastsurvival